Related Experiment Video
Updated: Apr 30, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Use of hypnosis to treat chronic somniloquy (sleep talking): a Case Report
1After Hours Hypnotherapy, Augusta, GA, United States.
Introduction:
This case study describes a hypnotherapeutic intervention for a 46-year-old man with chronic somniloquy that had persisted for decades, worsening during periods of stress. The patient sought treatment due to spousal complaints regarding the disturbance in her sleep.
Methods:
A treatment plan consisting of eight bi-weekly hypnotherapy sessions was developed and initiated. The intervention focused on clinical hypnosis as the primary therapeutic modality for addressing somniloquy.
Results:
The intervention yielded positive results. By the sixth scheduled session, the patient's wife reported that his sleep talking had been nearly completely eliminated, leading to an early discontinuation of treatment.
Discussion:
This case study suggests that clinical hypnosis may be a viable treatment option for chronic somniloquy. Further research is warranted to explore this therapeutic approach on a larger scale.
Related Concept Videos
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Management of Insomnia
Narcolepsy
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleep Apnea
The condition is more prevalent among...

